Clearing Up Atopic Dermatitis: Identification, Assessment, and Treatment
This activity outlines the identification, assessment, and treatment of atopic dermatitis.

Clearing Up Atopic Dermatitis: Identification, Assessment, and Treatment

Kimberly K. Dempsey, MPA, PA-C, DFAAPA; Denise Rizzolo, PhD, PA-C; Kara N. Roman, MMS, PA-C

While more than 70% of patients with atopic dermatitis (AD) are treated in the primary care setting, many clinicians have a suboptimal level of knowledge regarding determination of diagnosis and/or severity of AD. Throughout this activity, with the use of images and cases, participants will be better able to identify, rate the severity of, and choose appropriate treatment for AD. It is imperative that primary care PAs are knowledgeable about new and emerging agents for treatment (of which there are several), and how to best apply these agents in actual clinical situations.

Educational Objectives

At the conclusion of this activity, you should be able to:
  • Evaluate images of rashes to identify and diagnose AD
  • Assess severity over time using a multifactorial approach
  • Select (or refer for) appropriate treatment for AD, based on patient characteristics and available data on therapy options

Accreditation Statement


This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 Self-Assessment CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid through September 30, 2019.

Program Developer

Developed by AAPA in collaboration with The France Foundation.

Disclosure Policy Statement

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. The participating faculty reported the following:

Faculty

Kimberly K. Dempsey, MPA, PA-C, DFAAPA
Program Director and Associate Professor
Eastern Virginia Medical School
Norfolk, VA
No relevant commercial relationships to disclose

Denise Rizzolo, PhD, PA-C
Associate Professor
Kean University
Union, NJ
No relevant commercial relationships to disclose

Kara N. Roman, MMS, PA-C
Associate PA Program Director and Assistant Professor
Midwestern University
Downers Grover, IL
No relevant commercial relationships to disclose

Activity Planners

Marie-Michele Leger, MPH, PA-C
AAPA
Alexandria, VA
No relevant commercial relationships to disclose

Wendy Scales, PhD
The France Foundation
Old Lyme, CT
No relevant commercial relationships to disclose

Heather Tarbox, MPH
The France Foundation
Old Lyme, CT
No relevant commercial relationships to disclose

Off-Label/Unapproved Product(s) Discussion

Cyclosporine, Methotrexate, Mycophenolate Mofetil, Azatioprine

Disclaimer

The opinions and comments expressed by faculty and other experts, whose input is included in this program, are their own. This enduring material is produced for educational purposes only. Please review complete prescribing information of specific drugs mentioned in this program including indications, contraindications, warnings, and adverse effects and dosage before administering to patients.

Acknowledgement of Commercial Support

Supported by an independent educational grant from Pfizer.

AAPA offers no returns or refunds for online CME activities purchased through the AAPA store. All sales are final.


Type:     Internet Activity (Enduring Material)
383 Registered Users